Alaunos Therapeutics Alternatives & Competitors
12 companies similar to Alaunos Therapeutics — Attacking solid tumors with TCRs
Companies similar to Alaunos Therapeutics
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
2seventy bio
It’s about time we think smarter and faster than cancer.
Cambridge, United States
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
Houston, United States
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
Rival Readout
Competing with Alaunos Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
Alameda, United States
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
Seattle, United States
Verismo Therapeutics
The team that invented the first FDA-approved CAR-T therapy is back to revolutionize the s...
Philadelphia, United Stat...
Harpoon Therapeutics
SPEARHEADING IMMUNOTHERAPIES
South San Francisco, Unit...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Merus N.V.
Merus was acquired by Genmab. To see what’s new, visit Genmab.
Utrecht, The Netherlands
Immugenia Inc.
Developing the next generation CAR therapy using hemopoietic stem cells to treat cancer an...
About Alaunos Therapeutics
Alaunos Therapeutics is a pioneering force in the biotech sector, focusing on innovative solutions in the treatment of solid tumors through its proprietary Adoptive TCR-T cell therapy. The company's slogan, "Attacking solid tumors with TCRs," succinctly captures its mission-driven approach. Founded in 2005 and headquar...
Development of oral therapeutics for obesity, Preclinical research and evaluation, Drug development with improved tolerability profiles
Individuals with obesity, Patients with metabolic disorders
TCR-T Cell Therapy, Solid Tumors, Neoantigens, Genomic Mutations, Cellular Immuno-oncology, Gene Expression Technology, Cancer Treatment, Tumor-specific T Cells, Clinical Stage Company, Intrexon Corporation Partnership, RheoSwitch Therapeutic System, Phase 2 Clinical Studies, Interleukin-12, Small Molecule Therapeutics
B2B, B2D, B2C
Product Sales, Service Fee, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Alaunos Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Alaunos Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
